1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Avapritinib tablets are transforming the landscape for treatment of rare gastrointestinal stromal tumors (GIST) with PDGFRA exon 18 mutations. This report presents a focused analysis on evolving market opportunities, competitive positioning, supply-chain resilience, and adoption patterns for this targeted therapeutic across key global regions. Senior decision-makers will find actionable insights to inform clinical, manufacturing, and market-access strategies within a dynamic precision oncology sector.
Market Snapshot: Avapritinib Tablets Market Overview
The avapritinib tablets market is advancing as healthcare systems accelerate precision oncology deployment. Growing demand is driven by innovations in tyrosine kinase inhibitor design and regulatory endorsements, including accelerated approvals and breakthrough therapy designations. The North American region features robust uptake due to established infrastructure and payer alignment, while Asia Pacific is emerging as a high-growth segment owing to rising cancer incidence and supportive healthcare policies. Tariff adjustments in the United States and evolving regulatory pathways worldwide shape supply chain and access strategies.
Scope & Segmentation
- Indication: PDGFRA exon 18 mutant GIST, addressing highly specific molecular subtypes and minimizing off-target effects.
- Dosage Strength: 100 mg, 25 mg, 50 mg—allowing tailored regimens to optimize both efficacy and safety for variable patient profiles.
- Distribution Channel: Hospital pharmacies (private and public), online pharmacies, retail pharmacies—diversifying patient access and supporting adherence.
- End User: Cancer treatment centers (community and comprehensive), hospitals, specialty clinics (general and oncology)—enabling multidisciplinary care and streamlined administration.
- Regional Coverage: Americas (including United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
- Key Companies: Blueprint Medicines Corporation is the primary innovator, with generic entrants investing in future access and affordability models.
Key Takeaways: Strategic Insights for Decision Makers
- Adoption of avapritinib has shifted focus to biomarker-driven therapy, increasing utilization of companion diagnostics and precision protocols.
- Regulatory collaboration and outcome-based reimbursement models are supporting wider coverage, particularly in developed healthcare markets.
- Supply chain adaptations—including vertical integration and advanced analytics—are delivering improved resilience in response to tariff policy changes.
- Patient-centric care models, telehealth, and digital adherence programs enhance therapeutic impact and streamline follow-up for rare oncology indications.
- Regional partnerships and academic collaborations accelerate trial design, companion diagnostic integration, and post-marketing surveillance.
Tariff Impact: Effects on Avapritinib Market Dynamics
Recent United States tariff adjustments have affected raw material and active ingredient procurement, compelling manufacturers to optimize production, invest in local supplier networks, and pursue long-term agreements to stabilize costs. Advanced risk management and strategic stockpiling are emerging as essential tools in mitigating volatility and ensuring continuous therapeutic availability. The tariff environment has catalyzed greater supply-chain flexibility and collaboration with global partners.
Methodology & Data Sources
This report applies a multi-layered research methodology that includes detailed secondary analysis of peer-reviewed literature, regulatory filings, and clinical trial data. In addition, it incorporates expert interviews with oncologists, pharmaceutical executives, and healthcare policy leaders. Analytical rigor is ensured through data triangulation, modeling of supply chain scenarios, and peer review of findings.
Why This Report Matters
- Offers a thorough competitive benchmarking and technology adoption map for key stakeholders seeking to optimize avapritinib commercialization and patient access.
- Delivers insights on mitigating tariff- and policy-related supply chain disruptions, equipping decision-makers to maintain operational continuity.
- Helps inform resource allocation and partnership strategies by clarifying the clinical, regulatory, and regional factors shaping uptake.
Conclusion
Avapritinib tablets are redefining standards in targeted oncology, driving integration of diagnostics, personalized dosing, and advanced care pathways. Strategic collaboration, supply chain agility, and patient-centered frameworks will continue to shape market penetration and long-term success.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Impact of expanded FDA approvals in gastrointestinal stromal tumors on avapritinib commercial uptake
5.2. Role of companion diagnostic partnerships in improving patient selection for PDGFRA mutant therapies
5.3. Influence of payer reimbursement strategies on avapritinib market access and patient affordability
5.4. Emerging real-world evidence of long-term safety and efficacy influencing avapritinib treatment guidelines
5.5. Competitive landscape shifts with novel tyrosine kinase inhibitors entering the gastrointestinal stromal tumor space
5.6. Adoption challenges in rare PDGFRA exon 18 mutation subpopulations affecting avapritinib market penetration
5.7. Pricing dynamics and value-based contracting trends shaping avapritinib formulary placements globally
5.8. Impact of strategic collaborations between diagnostic and pharmaceutical companies on avapritinib adoption trajectories
5.9. Post marketing surveillance data driving label expansions and risk management plans for avapritinib tablets
5.2. Role of companion diagnostic partnerships in improving patient selection for PDGFRA mutant therapies
5.3. Influence of payer reimbursement strategies on avapritinib market access and patient affordability
5.4. Emerging real-world evidence of long-term safety and efficacy influencing avapritinib treatment guidelines
5.5. Competitive landscape shifts with novel tyrosine kinase inhibitors entering the gastrointestinal stromal tumor space
5.6. Adoption challenges in rare PDGFRA exon 18 mutation subpopulations affecting avapritinib market penetration
5.7. Pricing dynamics and value-based contracting trends shaping avapritinib formulary placements globally
5.8. Impact of strategic collaborations between diagnostic and pharmaceutical companies on avapritinib adoption trajectories
5.9. Post marketing surveillance data driving label expansions and risk management plans for avapritinib tablets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Avapritinib Tablets Market, by Indication
8.1. Introduction
8.2. Pdgra Exon 18 Mutant Gist
8.2. Pdgra Exon 18 Mutant Gist
9. Avapritinib Tablets Market, by Dosage Strength
9.1. Introduction
9.2. 100 Mg
9.3. 25 Mg
9.4. 50 Mg
9.2. 100 Mg
9.3. 25 Mg
9.4. 50 Mg
10. Avapritinib Tablets Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.2.1. Private Hospitals
10.2.2. Public Hospitals
10.3. Online Pharmacies
10.4. Retail Pharmacies
10.2. Hospital Pharmacies
10.2.1. Private Hospitals
10.2.2. Public Hospitals
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Avapritinib Tablets Market, by End User
11.1. Introduction
11.2. Cancer Treatment Centers
11.2.1. Community Cancer Centers
11.2.2. Comprehensive Cancer Centers
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Specialty Clinics
11.4.1. General Clinics
11.4.2. Oncology Clinics
11.2. Cancer Treatment Centers
11.2.1. Community Cancer Centers
11.2.2. Comprehensive Cancer Centers
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Specialty Clinics
11.4.1. General Clinics
11.4.2. Oncology Clinics
12. Americas Avapritinib Tablets Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Avapritinib Tablets Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Avapritinib Tablets Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Blueprint Medicines Corporation
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Blueprint Medicines Corporation
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. AVAPRITINIB TABLETS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AVAPRITINIB TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. AVAPRITINIB TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. AVAPRITINIB TABLETS MARKET: RESEARCHAI
FIGURE 24. AVAPRITINIB TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 25. AVAPRITINIB TABLETS MARKET: RESEARCHCONTACTS
FIGURE 26. AVAPRITINIB TABLETS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AVAPRITINIB TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. AVAPRITINIB TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. AVAPRITINIB TABLETS MARKET: RESEARCHAI
FIGURE 24. AVAPRITINIB TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 25. AVAPRITINIB TABLETS MARKET: RESEARCHCONTACTS
FIGURE 26. AVAPRITINIB TABLETS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AVAPRITINIB TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PDGRA EXON 18 MUTANT GIST, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PDGRA EXON 18 MUTANT GIST, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY 100 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY 100 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY 25 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY 25 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY 50 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY 50 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COMMUNITY CANCER CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COMMUNITY CANCER CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COMPREHENSIVE CANCER CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COMPREHENSIVE CANCER CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 100. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 101. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 108. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 109. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 112. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 113. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 114. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 115. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 116. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 117. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 120. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 121. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 125. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 126. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 127. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 195. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 196. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 197. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 198. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 199. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 202. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 203. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 206. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 207. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 211. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 214. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 215. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 218. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 219. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 222. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 223. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 243. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 246. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 247. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 250. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 251. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 254. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 255. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 256. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 257. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 258. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 259. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 262. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 263. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 266. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 267. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 270. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 271. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 272. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 273. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 308. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 323. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 324. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 325. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 326. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 327. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 330. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 331. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY END U
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PDGRA EXON 18 MUTANT GIST, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PDGRA EXON 18 MUTANT GIST, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY 100 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY 100 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY 25 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY 25 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY 50 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY 50 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COMMUNITY CANCER CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COMMUNITY CANCER CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COMPREHENSIVE CANCER CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY COMPREHENSIVE CANCER CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES AVAPRITINIB TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 100. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 101. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 108. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 109. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 112. CANADA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 113. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 114. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 115. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 116. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 117. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 120. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 121. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 125. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 126. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 127. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 195. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 196. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 197. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 198. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 199. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 202. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 203. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 206. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 207. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 211. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 214. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 215. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 218. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 219. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 222. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 223. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 243. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 246. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 247. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 250. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 251. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 254. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 255. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 256. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 257. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 258. ITALY AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 259. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 262. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 263. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 266. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 267. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 270. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 271. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 272. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 273. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 308. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY CANCER TREATMENT CENTERS, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA AVAPRITINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 323. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 324. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 325. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 326. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 327. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 330. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 331. DENMARK AVAPRITINIB TABLETS MARKET SIZE, BY END U
Samples
LOADING...
Companies Mentioned
The companies profiled in this Avapritinib Tablets market report include:- Blueprint Medicines Corporation
